KLOW peptide: components, amounts and research identity

KLOW peptide is a research blend of GHK-Cu, BPC-157, TB-500 and KPV. The specified formulation appears in Curo's KLOW 80 mg vial listing.

What is in the specified KLOW blend?

• GHK-Cu: 50 mg.

• BPC-157: 10 mg.

• TB-500: 10 mg.

• KPV: 10 mg.

Source: the supplier vial listing linked above. The stated masses add to 80 mg. These are label contents; a matching lot report provides a separate record of measured material.

Which primary records describe the four components?

GHK-Cu

FDA's PREZATIDE COPPER record maps GHK complex with copper and Copper Tripeptide-1 to UNII 6BJQ43T1I9. PubChem CID 165429100 gives a specific copper-complex representation. Copper-free GHK has a different reference identity. Sources: FDA PREZATIDE COPPER identity record and PubChem GHK-Cu reference, CID 165429100.

For the component, read GHK-Cu. The separate GHK-Cu component listing at Curo is a material destination.

BPC-157

PubChem identifies BPC-157 as CID 9941957. The tendon-cell paper describes a peptide with 15 residues. Sources: PubChem BPC-157 record, CID 9941957 and 2011 BPC-157 rat tendon-cell study, PMID 21030672.

TB-500

FDA's mapping identifies N-acetyl-Leu-Lys-Lys-Thr-Glu-Thr-Gln, also written Ac-LKKTETQ, the acetylated 17-23 fragment of thymosin beta-4. PubChem CID 62707662 is the corresponding fragment reference. Full-length thymosin beta-4 has a different identity. Sources: FDA TB-500 fragment identity record and PubChem acetylated fragment reference, CID 62707662.

The Research Peptide Guide TB-500 page explains the fragment distinction.

KPV

KPV is Lys-Pro-Val, a tripeptide recorded as PubChem CID 125672. Source: PubChem Lys-Pro-Val record, CID 125672.

These reference records identify components. A supplier's name on a vial still needs to be matched to the identity evidence for that lot.

Open the KLOW peptide source ledger.

For notes on how to identify the tested material in KLOW component papers, see the KLOW peptide tested-material notes.

Does KLOW have one chemical identity?

The four component records above describe separate reference molecules. One component's identifier, formula or molecular weight cannot describe this specified mixture. FDA also states that a UNII does not imply regulatory review or approval. Source: FDA TB-500 fragment identity record.

How do KLOW, GLOW and Wolverine differ?

The cited GLOW formulation shares GHK-Cu, BPC-157 and TB-500 with KLOW. KLOW adds KPV. Wolverine names a BPC-157 and TB-500 pairing; the cited example packages those two components separately. The KLOW vs GLOW vs Wolverine peptide comparison gives the ingredient amounts, packaging and supplier sources together.

Where are the study and material records?

KLOW peptide research and claim limits follows the component studies, their experimental models and the search for direct blend evidence. KLOW research-material and lot-document checks covers the listing and analytical report.

For the destination's reports, open Curo's lot certificates.